Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study [Gastrointestinal Cancer]
Conclusion
Obesity is associated with substantially increased CRC risk in patients with LS, but this risk is abrogated in those taking aspirin. Such patients are likely to benefit from obesity prevention and/or regular aspirin.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Movahedi, Bishop, Macrae, Mecklin, Moeslein, Olschwang, Eccles, Evans, Maher, Bertario, Bisgaard, Dunlop, Ho, Hodgson, Lindblom, Lubinski, Morrison, Murday, Ramesar, Side, Scott, Thomas, Vasen, Burn, Mathers Tags: Epidemiology Gastrointestinal Cancer Source Type: research
More News: Aspirin | Burns | Cancer | Cancer & Oncology | Colorectal Cancer | Eating Disorders & Weight Management | Epidemiology | Gastroenterology | HNPCC | Lynch Syndrome | Obesity | Study